wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35042588-C3DC17B7-DF97-4FDA-A817-081296E5A4A8
Q35042588-C3DC17B7-DF97-4FDA-A817-081296E5A4A8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35042588-C3DC17B7-DF97-4FDA-A817-081296E5A4A8
Solifenacin in multiple sclerosis patients with overactive bladder: a prospective study.
P2860
Q35042588-C3DC17B7-DF97-4FDA-A817-081296E5A4A8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35042588-C3DC17B7-DF97-4FDA-A817-081296E5A4A8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1651cc821c9a580392ef3b96e2f2b06bfdf8ef6a
P2860
Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder.